DHG Pharmaceutical Joint Stock Company

DHG Pharmaceutical Joint Stock Company, established in 1974, is a prominent entity within Vietnam's pharmaceutical and healthcare sectors. Headquartered in Can Tho, the company is dedicated to advancing public well-being by producing and distributing a wide array of healthcare products. Its mission centers on enhancing the quality of life for communities through accessible and effective pharmaceutical solutions. Operating primarily within Vietnam, DHG Pharma has built a reputation for its commitment to health initiatives and disease prevention programs.

With an employee base ranging from 1,000 to 5,000 individuals, DHG Pharmaceutical Joint Stock Company operates at a significant scale, generating $196.8M in revenue. The company focuses on manufacturing pharmaceutical products adhering to stringent quality standards, including GMP. Its operations encompass production, distribution, and a strong commitment to corporate social responsibility, actively supporting healthcare services and community health. For insights into the individuals driving these efforts, one can Meet DHG Pharmaceutical Joint Stock Company's team. This dedication extends to fostering long-term strategies for growth and public health impact.

DHG Pharmaceutical Joint Stock Company serves a diverse clientele, including healthcare providers and the general public, underscoring its dual B2B and B2C market approach. Its product portfolio is designed to address various health conditions, reflecting a comprehensive strategy in the pharmaceutical market. The company's presence in Asia, particularly in Vietnam, positions it as a key player in regional healthcare. Through continuous investment in its capabilities and a focus on community health, DHG Pharma aims to sustain its contribution to improving health outcomes and disease prevention across itsView more...